Mutations in lectin complement pathway genes COLEC11 and MASP1 cause 3MC syndrome
3MC syndrome has been proposed as a unifying term encompassing the overlapping Carnevale, Mingarelli, Malpuech and Michels syndromes. These rare autosomal recessive disorders exhibit a spectrum of developmental features, including characteristic facial dysmorphism, cleft lip and/or palate, craniosyn...
Saved in:
Published in | Nature genetics Vol. 43; no. 3; pp. 197 - 203 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
New York, NY
Nature Publishing Group
01.03.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | 3MC syndrome has been proposed as a unifying term encompassing the overlapping Carnevale, Mingarelli, Malpuech and Michels syndromes. These rare autosomal recessive disorders exhibit a spectrum of developmental features, including characteristic facial dysmorphism, cleft lip and/or palate, craniosynostosis, learning disability and genital, limb and vesicorenal anomalies. Here we studied 11 families with 3MC syndrome and identified two mutated genes, COLEC11 and MASP1, both of which encode proteins in the lectin complement pathway (collectin kidney 1 (CL-K1) and MASP-1 and MASP-3, respectively). CL-K1 is highly expressed in embryonic murine craniofacial cartilage, heart, bronchi, kidney and vertebral bodies. Zebrafish morphants for either gene develop pigmentary defects and severe craniofacial abnormalities. Finally, we show that CL-K1 serves as a guidance cue for neural crest cell migration. Together, these findings demonstrate a role for complement pathway factors in fundamental developmental processes and in the etiology of 3MC syndrome. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 AUTHOR CONTRIBUTIONS CR planned, performed experiments, analysed data and co-wrote the manuscript; ADF planned, performed experiments, analysed data and co-wrote the manuscript; DO planned, performed experiments, analysed data and co-wrote the manuscript; EC performed experiments and analysed data; VHH performed experiments and analysed data; HS performed experiments; JK performed experiments; AW performed experiments and analysed data; DJ performed experiments; AAK clinically ascertained patients and samples; GFL clinically ascertained patients and samples; BD clinically ascertained patients and samples; FC clinically ascertained patients and samples; MB clinically ascertained patients and samples and planned study; ML clinically ascertained patients and samples; RH clinically ascertained patients and samples, planned study, analysed data and edited ms; PS provided samples and analysed data; AJB planned, performed experiments and analysed data; HP planned, performed experiments and analysed data. FSA planned study, ascertained samples, performed experiments, analysed data and edited ms. PLB planned, supervised, analysed data, co-wrote and edited ms. These authors contributed equally |
ISSN: | 1061-4036 1546-1718 |
DOI: | 10.1038/ng.757 |